PUBLICACIONES 

COMO AUTORA

  1. Sampayo-Cordero M., Miguel-Huget B., Malfettone A., Pérez-García J.M., Llombart-Cussac A., Cortés J., Pardo A., and Pérez-López, J. The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II). Int. J. Environ. Res. Public Health. 2020; 17: 6590.

https://www.mdpi.com/1660-4601/17/18/6590?type=check_update&version=2

 

  1. Sampayo-Cordero M, Miguel-Huget B, Pardo-Mateos A, et al. Agreement between the results of meta-analyses from case reports and from clinical studies regarding the efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age: An example of case reports meta-analyses as an useful tool for evidence-based medicine in rare diseases. Molecular Genetics and Metabolism. 2018; 123:69–75.

https://pubmed.ncbi.nlm.nih.gov/29336994/

 

  1. Pardo-Mateos, A. and Young C.S.H. A 40 kDa isoform of the type 5 adenovirus IVa2 protein is sufficient for virus viability. Virology. 2004; 324(1):151-64.

https://www.sciencedirect.com/science/article/pii/S0042682204001709

 

  1. Pardo-Mateos, A. and Young C.S.H.. Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo. Virology. 2004; 327(1):50-9.

https://www.sciencedirect.com/science/article/pii/S0042682204003915?via%3Dihub

 

  1. Almudena Pardo. Comentarios de trabajos científicos: La vacunación oronasal con un replicón del virus de la peste porcina clásica (CSFV) con una delección parcial o total del gen E2 induce una protección parcial contra un «challenge» letal de CSFV altamente virulento. Avances en tecnología porcina, 2005; 2 (7-8):54-57.

https://dialnet.unirioja.es/servlet/articulo?codigo=4997647

 

  1. Abstract: Pardo-Mateos, A. and Young C.S.H. Genetic analysis of adenovirus IVa2 protein. Presentación de pósteren ICRF/UCSF 2001 DNA Tumor Virus Meeting. Cambridge, U.K. Julio 2001.

 

  1. Abstract: Pardo-Mateos, A. and Young C.S.H. The second methionine in the adenovirus IVa2 ORF may be used to produce a 40kDa protein capable of allowing viral replication. Presentación de póster en ICGEB 2003 DNA Tumor Virus Meeting. Trieste, Italia. Julio 2003.